ICIsimmune checkpoint inhibitorspembrolizumabdurvalumabnivolumabNSCLCnon-small-cell lung cancerAdenocarcinoma
…g survival outcomes in very elderly NSCLC patients treated with ICIs. Despite limited statistical power, these parameters may suppor…
Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…g survival outcomes in very elderly NSCLC patients treated with ICIs. Despite limited statistical power, these parameters may suppor…
…ty, and improved immune responses. In summary, the advantage of immunotherapy diminished progressively with age. ICIs were associated with fa…
…en JBAG, Blank CU, Beets-Tan RGH. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol. 2019; 30:998–…